Literature DB >> 12930382

A selective history of the therapy of Hodgkin's disease.

Vincent T DeVita1.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12930382     DOI: 10.1046/j.1365-2141.2003.04541.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  6 in total

1.  A Historical Tale of Two Lymphomas: Part I: Hodgkin lymphoma.

Authors:  Ritu Lakhtakia; Ikram Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2015-05-28

2.  Cause-Specific Mortality Following Initial Chemotherapy in a Population-Based Cohort of Patients With Classical Hodgkin Lymphoma, 2000-2016.

Authors:  Graça M Dores; Rochelle E Curtis; Nicole H Dalal; Martha S Linet; Lindsay M Morton
Journal:  J Clin Oncol       Date:  2020-09-18       Impact factor: 44.544

3.  The results of Hodgkin lymphoma treatment in children in the period 1997-2006.

Authors:  Edo Hasanbegović; Snijezana Sabanović
Journal:  Bosn J Basic Med Sci       Date:  2008-02       Impact factor: 3.363

4.  DNA methylation patterns of adult survivors of adolescent/young adult Hodgkin lymphoma compared to their unaffected monozygotic twin.

Authors:  Jun Wang; David Van Den Berg; Amie E Hwang; Daniel Weisenberger; Timothy Triche; Bharat N Nathwani; David V Conti; Kim Siegmund; Thomas M Mack; Steve Horvath; Wendy Cozen
Journal:  Leuk Lymphoma       Date:  2019-01-22

5.  Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma.

Authors:  Valiollah Mehrzad; Farzaneh Ashrafi; Ali Reza Farrashi; Reyhaneh Pourmarjani; Mehdi Dehghani; Armindokht Shahsanaei
Journal:  Adv Biomed Res       Date:  2017-03-07

Review 6.  Cardiotoxicity of Novel Targeted Hematological Therapies.

Authors:  Valentina Giudice; Carmine Vecchione; Carmine Selleri
Journal:  Life (Basel)       Date:  2020-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.